Nov 20 (Reuters) - Acerus Pharmaceuticals Corporation ASP.TO :
* Reports approval of estrace generic in Canada
* Says reported that health Canada has granted a notice of compliance (noc) for
a generic version of estrace
* Says as far as the company is aware, the product is currently not available
on the Canadian market
* Co is monitoring situation and evaluating possible impact if any that
potential launch could have on estrace sales going forward
* Source text for Eikon urn:newsml:reuters.com:*:nBw8hL90Ta
* Further company coverage ASP.TO